HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 962918Erstellt: 25. Oktober 2026
Hydrochloric Acid → Aminophenazone hydrochloride
https://huagongshe.com/reaction/962918
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Hydrochloric Acid | HCID 313 | — |
| Edukt | 4-Aminoantipyrine | HCID 2151 | — |
| Edukt | Aminopyrine | HCID 6009 | — |
| Edukt | Acetonitrile | HCID 6342 | — |
| Edukt | Methylaminoantipyrine | HCID 10618 | — |
| Edukt | 4-(Formylamino)antipyrine | HCID 72666 | — |
| Edukt | 3-Hydroxymethylaminopyrine | HCID 3082031 | — |
| Edukt | 4-Formylamino-2-methyl1-phenyl-3-pyrazolin-5-one | HCID 18913459 | — |
| Edukt | 2,3-Dimethyl-4-hydroxyamino-1-phenyl-3-pyrazolin-5-one | HCID 18913460 | — |
| Edukt | 4-Formylamino-3-hydroxymethyl-2methyl-1-phenyl-3-pyrazolin-5-one | HCID 18913461 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Lösungsmittel | Diethyl Ether | HCID 3283 | — |
| Produkt | Aminophenazone hydrochloride | HCID 18913462 | — |
Reaktionsschritte
Aminopyrine hydrochloride was prepared from the free base (Aldrich) by treatment with HCl in ether. lodosobenzene (1650 mg, 7.5 mmol, prepared according to the method of Saltzman et al., Org. Synth., 43:60-61 (1963)) was added with stirring at room temperature in portions every 30 min to a solution of octachloro-octachloro tetrasulfonato Fe(III) porphyrin (6.2 mg 3.9 μmol) in 50 ml of 80:20 H2O:CH3CN containing 678 mg (3.0 mmol) of aminopyrine. Two hr after the last addition of the oxidant, the solution was evaporated under reduced pressure at 50° C. The residue was dissolved in 20 ml of aqueous Na2CO3 solution, and the solution was extracted with CH2Cl2 (3×50 ml). The organic layer was dried over Na2CO3 and evaporated under reduced pressure. The residue was chromatographed on silica gel, eluting with 1:25 methanol:methylene chloride. Seven oxidation products were obtained from the eluate (see Scheme 2): 2,3-dimethyl-4-monomethylamino-1-phenyl-3-pyrazolin5-one (AP-1); 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-2); 4formylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-3); 2,3-dimethyl-4hydroxyamino-1-phenyl-3-pyrazolin-5-one (AP-4); 4-dimethylamino-3hydroxymethyl-2-methyl-1-phenyl-3-pyrazolin-5-one (AP-5); 4-dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one-4-oxide (AP-6); and 4-dimethyl-2,3dimethyl-1-(4-hydroxyphenyl)-3-pyrazolin-5-one (AP-7), 4-formylamino-2-methyl1-phenyl-3-pyrazolin-5-one (AP-8), and 4-formylamino-3-hydroxymethyl-2methyl-1-phenyl-3-pyrazolin-5-one (AP-9).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US05760216 |
|---|
| Quelldatensatz | uspto-grants-1998_06 |
|---|
| ORD ID | ord-71c73e3a87404acf82e5763a8c983f19 |
|---|
| Quellennotiz | uspto-grants-1998_06 |
|---|